Healthcare -
Biotechnology - NASDAQ - US
$ 7.87
6.21 %
$ 666 M
Market Cap
-3.2
P/E
VERV - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity VERV - Verve Therapeutics, Inc.
753 M
LAST VALUE
39.98%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR